Concepedia

Xunshuai Zhu

XZ

Statistics

Publications

6

Citations

215

H-Index

6

Active since

2016

Affiliations

Guangxi Medical University(Current)

Guangxi University of Chinese Medicine

Institute of Bioengineering and Nanotechnology

Xunshuai Zhu is an author at Guangxi Medical University specializing in liver disease, hepatic pathophysiology, and pharmacology.

Publications per year

2016–2020

6

Publications

6

Didymin Alleviates Hepatic Fibrosis Through Inhibiting ERK and PI3K/Akt Pathways via Regulation of Raf Kinase Inhibitor Protein

Xing Lin, Faicheng Bai, Jinlan Nie et al. · Cellular Physiology and Biochemistry · 2016 · 66 citations · Full text

, , +17

Trolline Ameliorates Liver Fibrosis by Inhibiting the NF-κB Pathway, Promoting HSC Apoptosis and Suppressing Autophagy

Facheng Bai, Quanfang Huang, Jinlan Nie et al. · Cellular Physiology and Biochemistry · 2017 · 44 citations · Full text

, , +17

RETRACTED: Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression

Quanfang Huang, Facheng Bai, Jinlan Nie et al. · International Immunopharmacology · 2016 · 43 citations

, , +16

HBOA ameliorates CCl4-incuded liver fibrosis through inhibiting TGF-β1/Smads, NF-κB and ERK signaling pathways

Xuemei Sun, Xiukun Huang, Xunshuai Zhu et al. · Biomedicine & Pharmacotherapy · 2019 · 29 citations · Full text

, , +17

4-hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice

Hongyuan Wang, Xiugui Wei, Xian Fu Wei et al. · International Immunopharmacology · 2020 · 23 citations

, , +7

1–5 of 6